Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats
- PMID: 23344574
- PMCID: PMC3602696
- DOI: 10.1152/ajprenal.00645.2012
Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats
Abstract
Genetic hypercalciuric stone-forming (GHS) rats, bred to maximize urine (U) calcium (Ca) excretion, have increased intestinal Ca absorption and bone Ca resorption and reduced renal Ca reabsorption, leading to increased UCa compared with the Sprague-Dawley (SD) rats. GHS rats have increased vitamin D receptors (VDR) at each of these sites, with normal levels of 1,25(OH)(2)D(3) (1,25D), indicating that their VDR is undersaturated with 1,25D. We tested the hypothesis that 1,25D would induce a greater increase in UCa in GHS rats by feeding both strains ample Ca and injecting 1,25D (25 ng · 100 g body wt(-1) · day(-1)) or vehicle for 16 days. With 1,25D, UCa in SD increased from 1.7 ± 0.3 mg/day to 24.4 ± 1.2 (Δ = 22.4 ± 1.5) and increased more in GHS from 10.5 ± 0.7 to 41.9 ± 0.7 (Δ = 29.8 ± 1.8; P = 0.003). To determine the mechanism of the greater increase in UCa in GHS rats, we measured kidney RNA expression of components of renal Ca transport. Expression of transient receptor potential vanilloid (TRPV)5 and calbindin D(28K) were increased similarly in SD + 1,25D and GHS + 1,25D. The Na(+)/Ca(2+) exchanger (NCX1) was increased in GHS + 1,25D. Klotho was decreased in SD + 1,25D and GHS + 1,25D. TRPV6 was increased in SD + 1,25D and increased further in GHS + 1,25D. Claudin 14, 16, and 19, Na/K/2Cl transporter (NKCC2), and secretory K channel (ROMK) did not differ between SD + 1,25D and GHS + 1,25D. Increased UCa with 1,25D in GHS exceeded that of SD, indicating that the increased VDR in GHS induces a greater biological response. This increase in UCa, which must come from the intestine and/or bone, must exceed any effect of 1,25D on TRPV6 or NCX1-mediated renal Ca reabsorption.
Figures



Similar articles
-
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.Calcif Tissue Int. 2014 May;94(5):531-43. doi: 10.1007/s00223-014-9838-7. Epub 2014 Jan 31. Calcif Tissue Int. 2014. PMID: 24481706 Free PMC article.
-
1,25(OH)₂D₃-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet.Am J Physiol Renal Physiol. 2013 Oct 15;305(8):F1132-8. doi: 10.1152/ajprenal.00296.2013. Epub 2013 Aug 7. Am J Physiol Renal Physiol. 2013. PMID: 23926184 Free PMC article.
-
Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.Am J Physiol Renal Physiol. 2014 May 1;306(9):F1081-7. doi: 10.1152/ajprenal.00680.2013. Epub 2014 Feb 26. Am J Physiol Renal Physiol. 2014. PMID: 24573387 Free PMC article.
-
Modeling hypercalciuria in the genetic hypercalciuric stone-forming rat.Curr Opin Nephrol Hypertens. 2015 Jul;24(4):336-44. doi: 10.1097/MNH.0000000000000130. Curr Opin Nephrol Hypertens. 2015. PMID: 26050120 Free PMC article. Review.
-
Hypercalciuria: lessons from studies of genetic hypercalciuric rats.J Am Soc Nephrol. 1994 Nov;5(5 Suppl 1):S54-8. doi: 10.1681/ASN.V55s54. J Am Soc Nephrol. 1994. PMID: 7873746 Review.
Cited by
-
Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.Kidney Int. 2021 May;99(5):1118-1126. doi: 10.1016/j.kint.2020.12.023. Epub 2021 Jan 5. Kidney Int. 2021. PMID: 33417997 Free PMC article.
-
Molecular pharmacology of the onco-TRP channel TRPV6.Channels (Austin). 2023 Dec;17(1):2266669. doi: 10.1080/19336950.2023.2266669. Epub 2023 Oct 15. Channels (Austin). 2023. PMID: 37838981 Free PMC article. Review.
-
Structure-function analyses of human TRPV6 ancestral and derived haplotypes.Structure. 2025 Jan 2;33(1):91-103.e5. doi: 10.1016/j.str.2024.10.018. Epub 2024 Nov 4. Structure. 2025. PMID: 39500315
-
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.Calcif Tissue Int. 2014 May;94(5):531-43. doi: 10.1007/s00223-014-9838-7. Epub 2014 Jan 31. Calcif Tissue Int. 2014. PMID: 24481706 Free PMC article.
-
Molecular pathway and structural mechanism of human oncochannel TRPV6 inhibition by the phytocannabinoid tetrahydrocannabivarin.Nat Commun. 2023 Aug 2;14(1):4630. doi: 10.1038/s41467-023-40362-2. Nat Commun. 2023. PMID: 37532722 Free PMC article.
References
-
- Adams ND, Gray RW, Lemann JJ. Effects of calcitriol administration on calcium metabolism in healthy men. Kidney Int 21: 90–97, 1982 - PubMed
-
- Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 51: 640–645, 1997 - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous